Cargando…
Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder
This study assessed prevention of relapse in patients with treatment-resistant depression (TRD) taking olanzapine/fluoxetine combination (OFC). Patients with major depressive disorder (MDD) who failed to satisfactorily respond to ⩾2 different antidepressants for ⩾6 weeks within the current MDD episo...
Autores principales: | Brunner, Elizabeth, Tohen, Mauricio, Osuntokun, Olawale, Landry, John, Thase, Michael E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207330/ https://www.ncbi.nlm.nih.gov/pubmed/24801768 http://dx.doi.org/10.1038/npp.2014.101 |
Ejemplares similares
-
Olanzapine and fluoxetine combination in severe or resistant depression
por: Haridas, R.M., et al.
Publicado: (2003) -
The return of fixed combinations in psychiatry: fluoxetine and olanzapine combination
por: Shelton, Richard C
Publicado: (2006) -
Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination
por: Walker, Daniel J., et al.
Publicado: (2017) -
Weight loss dynamics during combined fluoxetine and olanzapine treatment
por: Perrone, Jennifer A, et al.
Publicado: (2004) -
Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues
por: Bobo, William V, et al.
Publicado: (2009)